HeartBeam picks Triple Ring to co-develop portable heart attack detector

HeartBeam (Nasdaq: BEAT) said today that it has signed a professional services agreement with Triple Ring Technologies to help develop and design its personal, portable heart attack detector.

Santa Clara, California-based HeartBeam said it plans to submit what it calls a “telehealth complete solution 3D vector electrocardiogram (ECG) collection device” for FDA 510(k) clearance in the fourth quarter of 2022.

The company said patients will be able to use the credit-card-sized device at home to help their doctors determine whether chest pain is due to a myocardial infarction (the medical term for a heart attack) using cloud-based software for real-time data transmission.

The project includes device builds for design verification and validation, device packaging and a manufacturing technology transfer. HeartBeam said it is talking with several contract manufacturers.

“The joint effort will be a five-phase expedited device development proje…

Read more
  • 0

Philips launches at-home, 12-lead ECG for clinical trials

Philips’ new 12-lead, at-home ECG. [Image courtesy of Philips]Royal Philips (NYSE: PHG, AEX: PHIA) announced today that it is expanding its remote cardiac monitoring portfolio with a patch-based, clinical-grade ECG.

The new at-home electrocardiogram monitors could reduce the need for site visits during clinical trials, according to the Dutch medtech giant. At-home ECG is a hot space: iRhythm Technologies CEO Quentin Blackford recently spoke with Medical Design & Outsourcing about iRhythm’s plans to roll out asymptomatic atrial fibrillation (AFib) screening pilots with payors in 2022.

Get the full story on our sister site Medical Design & Outsourcing. 

Read more
  • 0